Lucid Diagnostics (LUCD) Stock: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$0.59
-0.03 (-5.42%)
▼
5d:
-26.36%
30d:
-37.63%
90d:
-42.4%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LUCD is down 26.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LUCD is down 26.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $0.59, which is considered oversold relative to its 30-day fair value range of $0.73 to $0.94.
Technical Outlook: Technically, LUCD is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.91. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: LUCD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+574.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUCD is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.91. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: LUCD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+574.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.73 -
$0.94
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 574.2% below Wall St target ($4.00)
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.73 -
$0.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.50
Resistance Level
$0.91
Current Trend
Downtrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.60
Wall Street Target
$4.00
(+574.2%)
Revenue Growth (YoY)
26.7%
Share & Embed Analysis
Last updated: October 05, 2026 6:36 PM ET
Data refreshes hourly during market hours. Next update: 7:36 PM
Data refreshes hourly during market hours. Next update: 7:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
STRONG BUY
28 analysts |
$368 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$101 | 60 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
28 analysts |
$95 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$121 | 55 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
20 analysts |
$83 | 64 BUY |
